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Abstract
Background: Functional GABAB receptor is believed to require hetero-dimerization between GABAB1 (GB1) and GABAB2
(GB2) subunits. The GB1 extracellular domain is required for ligand binding, and the GB2 trans-membrane domain is
responsible for coupling to G proteins. Atypical GABAB receptor responses observed in GB2-deficient mice suggested that
GB1 may have activity in the absence of GB2. However the underlying mechanisms remain poorly characterized.
Methodology/Principal Findings: Here, by using cells overexpressing a GB1 mutant (GB1asa) with the ability to translocate
to the cell surface in the absence of GB2, we show that GABAB receptor agonists, such as GABA and Baclofen, can induce
ERK1/2 phosphorylation in the absence of GB2. Furthermore, we demonstrate that GB1asa induces ERK1/2 phosphorylation
through Gi/o proteins and PLC dependent IGF-1R transactivation.
Conclusions/Significance: Our data suggest that GB1 may form a functional receptor at the cell surface in the absence of
GB2.
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Introduction
c-aminobutyric acid (GABA) is a major inhibitory neurotrans-
mitter in the mammalian central nervous system (CNS) [1] which
mediates fast synaptic inhibition through ionotropic GABAA and
GABAC receptors, as well as slow and prolonged synaptic
inhibition through metabotropic GABAB receptor [2]. The
GABAB receptor belongs to the class C G protein coupled
receptors (GPCRs) and is composed of two distinct subunits,
GABAB1 (GB1) and GABAB2 (GB2) [3–7]. The GB1 subunit binds
to GABA, while the GB2 is responsible for the activation of Gi/o
proteins [8,9]. Evidence suggests that GB1 and GB2 hetero-
dimerization is required for functional receptor formation. Cell
surface trafficking of the GABAB receptor is controlled by an
endoplasmic reticulum (ER) retention signal (RSRR motif) in the
intracellular C-terminus of the GB1 subunit. GB1 alone can’t
translocate to the cell surface unless associated with GB2, through
which the coil-coiled interaction between the C-terminus masks
the ER retention signals [10,11]. A mutation of the ER retention
signal from RSRR to ASAR (GB1asa) allows GB1 to reach the cell
surface independently [12].
During embryonic development, GB1 mRNA is detected in the
hippocampalformation,cerebralcortex,intermediateandposterior
neuroepithelium and the pontine neuroepithelium at E12, Howev-
er, GB2 mRNA and protein are not detected at the same period in
thecentralneuronalsystem(CNS)[13].Inadultorganisms,whereas
GB2 expression is limited to the brain [3], expression of GB1 is
observed in most CNS regions and in peripheral tissues [1,14–17].
GB1 and GB2 mRNAs are equally abundant in the cortex,
thalamus, medial and lateral geniculate bodies, habenula, and
cerebellum. Whereas the levels of GB2 mRNA are low to
undetectable in caudater/putamen, hypothalamus, septum, preop-
ticarea,andsubstantianigra,GB1mRNAispresentatmoderate to
high levels. Likewise, whereas GB2 mRNA is undetectable in glial
cells of white matter throughout the rat brain and spinal cord,
expressionofGB1mRNAisdetectedinglialcellsofallwhitematter
and in glia throughout many areas of the brain [18]. These reports
suggest that GB1 may be able to homodimerize, or heterodimerize
withanunrecognizedpartner,andthusmayexertGABABreceptor-
mediated physiological functions in the absence of GB2. Indeed,
GB2-deficient (GB2
2/2) mice show atypical electrophysiological
GABAB receptor responses in hippocampal slices [19]. However, in
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the cell surface, and how this effect is mediated, is not known.
In the present study, GB1asa-transfected HEK293 cells are used
to address whether GB1asa at the cell surface is sufficient to induce
ERK1/2 phosphorylation as a functional GABAB receptor would
do [20,21]. We find that selective activation of GB1asa leads to
ERK1/2 phosphorylation through Gi/o proteins and phospholi-
pase C (PLC). Even more interestingly, we demonstrate that
GB1asa-induced ERK1/2 phosphorylation occurs through trans-
activation of the IGF-1 receptor (IGF-1R).
Materials and Methods
Materials
GABA and IGF-1 were purchased from Sigma-Aldrich (St.
Louis, MO, USA). Baclofen and CGP54626 were purchased from
Tocris (Fisher-Bioblock, Illkrich, France). Pertussis toxin (PTX),
U73122 and U73343 were purchased from Merck Biosciences
(Darmstadt, Germany). Dulbecco’s modified Eagle’s medium
(DMEM), penicillin, fetal bovine serum (FBS) and other solutions
used for cell cultures were purchased from Invitrogen (Shanghai,
China). PRK6 plasmids encoding wild-type GB1 and GB2 and
mutant GB1asa with an epitope tag at their N-terminal ends under
the control of a cytomegalovirus promoter were described
previously [12]. Primary antibodies including phospho-p44/42
MAP kinase (T202/Y204) (# 9101) antibody, p44/42 MAPK (#
9102) antibody, phospho-Tyr1135/1136 IGF-IR antibody (19H7),
IGF-IR antibody (111A9), were purchased from Cell Signaling
Technology (Beverly, MA, USA). Anti-GB1 antibody (Ab55051)
was purchased from Abcam (Cambridge, UK). Anti-GB2 (C-
terminal) antibody was from Invitrogen (Shanghai, China). Anti-
Flag-M2 monoclonal antibody was purchased from Sigma-Aldrich
(St. Louis, MO, USA).
Cell Culture and Transfection
Human embryonic kidney HEK293 cells were kindly provided
by Dr. Philippe Rondard (Institut de Ge ´nomique Fonctionnelle,
Montpellier, France) [21]. Mouse embryonic fibroblast (MEF) cells
were kindly provided by Dr. Steve P. Balk (Beth Israel Deaconess
Medical Center, Harvard Medical School, Boston, MA, USA)
[22]. HEK293 cells were cultured in Dulbecco’s modified Eagle’s
medium supplemented with 10% FBS and transfected by
electroporation as described previously [23] or by lipofectamine
2000. For electroporation transfection, cells (10
7) were transfected
with plasmid DNA containing cDNAs encoding GB1asa (4 mg) or
GB1 (4 mg) or GB2 (4 mg), with the addition of pRK6 vector to a
total amount of 10 mg of plasmid DNA. For lipofectamine 2000
transfection, cells in 6-well plates were transfected with plasmid
DNA containing cDNAs encoding GB1asa (500 ng) or GB1
(300 ng) or GB2 (500 ng), with the addition of pRK6 vector to a
total amount of 800 ng of plasmid DNA.
Quantification of Cell Surface Expression and Total
Expression of GB1 by ELISA
After transfection with HA-tagged versions of the constructs by
Lipofectamine 2000 according to the manufacturer’s protocol,
HEK-293 cells were grown in DMEM at 37uC in a humidified
atmosphere containing 95% air and 5% CO2 overnight and then
split into white-walled, clear bottom 96-well plates coated with
poly-L-lysine. 24 hrs later cells were washed twice with PBS, fixed
with 4% paraformaldehyde in PBS (non-permeabilized for
detection of thecell surface expression), or fixed with 4%
paraformaldehyde and 0.1% Triton-100 in PBS (permeabilized
for detection of the total expression), then blocked with PBS and
1% fetal calf serum.After 30 min incubation, the anti-HA
monoclonal antibody conjugated with horseradish peroxidase
(clone3F10, Roche Bioscience, Basel, Switzerland) was applied for
30 min and cells were washed. Bound antibody was detected by
chemoluminescence using SuperSignal substrate (Pierce, Rock-
ford, IL, USA) and a 2103 EnVision
TM Multilabel Plate Readers
(Perkin Elmer, Waltham, MA, USA).
RNA Extraction and RT-PCR
24 hours after transfection, total RNA was extracted using
Trizol and isolated according to the procedure supplied by the
manufacturer (Invitrogen). Reverse transcription was carried out
according to the manufacturer’s protocol (Invitrogen). The first
strand of the cDNA was generated from 4 mg of total RNA using
oligo-dT primer and M-MLV reverse transcriptase (Invitrogen).
Nucleotide primers were prepared based on the sequences of
human GB2 and b-actin. The sequences of these oligonucleotide
primers were as follows: Primer for human GB2 (851 bp), 59-
ACCATCAGGTTCCAAGGATC-39(forward) and 59-AGGCA-
GAGGGTGATGGTGCT-39 (reverse). Primer for human b-actin
(290 bp): 59-CGGAACCGCTCATTGCC-39 (forward); antisense,
59-ACCCACACTGTGCCCATCTA-39 (reverse). The PCR was
performed initially by denaturation at 94uC for 5 min, followed by
30 cycles of denaturation at 94uC for 1 min, annealing at 57uC for
1 min, extension at 72uC for 45 s (for GABABR2, duration of
90 s), and a final extension step at 72uC for 10 min. Amplified
DNA fragments were electrophoretically fractionated on 1%
agarose gels.
RNAi Transfection in Mouse Embryonic Fibroblast (MEF)
Cells
IGF-R RNAi knockdown experiment using MEF cells were
performed as previously described [24]. MEF cells were first
transfected with shRNA and then with GB1asa (1 mg) by
lipofectamine 2000. After 24 hrs, cells were treated with inhibitory
compounds.
Drug Treatments
Cultures were washed once with Ca
2+-free HEPES-buffered
solution (HBS) (containing 10 mM HEPES, pH 7.4, 140 mM
NaCl, 4 mM KCl, 2 mM MgSO4 and 1 mM KH2PO4) and
pre-incubated at 37uC with or without indicated inhibitors
dissolved in HBS for 60 min. For PTX treatment, the cultures
were pretreated for 14–16 hrs with PTX (200 ng/ml) or left
untreated. Cells were then stimulated for the indicated time by
incubating with GABA or IGF-1 prepared in fresh HBS.
Inhibitors were dissolved in HBS with or without dimethyl
sulfoxide (DMSO) or/and alcohol. Whenever DMSO or/and
alcohol were used, HBS containing the same concentration of
DMSO, alcohol, or both were used as the control vehicle. At
the end of the treatment, the cells were quickly washed with
ice-cold Ca
2+-free PBS at pH 7.4, and 200 ml ice-cold lysis
buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1%SDS, 1 mM
EDTA, 2.5 mM Sodium pyrophosphate, 1 mM b-glycerophos-
phate, 1 mM Na3VO4,1mg/ml leupeptin, 1 mM PMSF) was
added to the cells and placed immediately on ice.
Western Blot Analysis
Cell lysates were sonicated and protein concentrations were
determined using Bradford reagent (Bio-Rad Laboratories Ltd.,
Hertfordshire, UK). Lysates were mixed with 4X SDS sample
loading buffer (0.25 M Tris pH 6.8, 8% SDS, 40% glycerol,
0.4 M DTT, 0.04% bromophenol blue). Samples were boiled for
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SDS-PAGE on 8–12% gels. Proteins were transferred to
nitrocellulose membranes (Millipore, Bedford, MA) and blocked
in blocking buffer (5% nonfat dry milk in TBS and 0.1% Tween
20) for 1 hr at room temperature. The blots were then incubated
with primer antibodies at the relevant dilution overnight at 4uC,
and with horseradish peroxidase-linked secondary antibodies for
2 hrs. Immunoblots were detected using enhanced chemilumines-
cence reagents (Pierce Protein Research Products, Rockford, IL,
USA) and visualized on X-ray film. The density of immunoreac-
tive bands was measured by NIH imaging software, and all bands
were normalized to percentages of control values.
Statistical Analysis
Data are presented as means 6 SEM of at least three
independent experiments. Statistical analysis was performed by
Student’s t-test. Values with p,0.05 were considered statistically
significant.
Results
GB1asa can Induce ERK1/2 Phosphorylation Independent
of GB2
Functional heterodimeric GABAB receptor induces ERK1/2
phosphorylation in neurons [20,21]. To test whether GB1 can
activate ERK1/2 phosphorylation in the absence of GB2,
HEK293 cells were transfected with a GB1 mutant, GB1asa.
This mutant is able to translocate to the cell surface independent
of GB2. Specific GABAB receptor agonists, such as GABA
(100 mM) or Baclofen (100 mM), induced ERK1/2 phosphoryla-
tion in a transient manner in cells overexpressing only GB1asa
(Fig. 1A). We further evaluated the effect of the GABAB receptor-
Figure 1. GB1asa can induce ERK1/2 phosphorylation independent of GB2. (A) Effects of GABA (100 mM) and Baclofen (100 mM) on ERK1/2
phosphorylation in cells overexpressing GB1asa over the indicated time course. (B) Effects of CGP54626 on GABA-induced ERK1/2 phosphorylation.
CGP54626 (10 mM; 20 min) is incubated before treatment with GABA (100 mM; 3 min). (C) Detection of expression of
HAGB1asa alone or
HAGB1 in the
presence of
FlagGB2 by ELISA (upper panel) and Western blots (lower panel). (D) Time course of the ERK1/2 phosphorylation induced by GABA
(100 mM) in the HEK293 cells transfected with both GB1 and GB2 or GB1asa alone. The representative western blots are shown under the quantified
data of ERK1/2 phosphorylation analyzed from at least three separate experiments (mean 6 SEM).
doi:10.1371/journal.pone.0039698.g001
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phosphorylation. CGP54626 pretreatment (10 mM) blocked
GABA (100 mM)-induced ERK1/2 phosphorylation (Fig. 1B),
thereby demonstrating that selective activation of GB1asa induced
ERK1/2 phosphorylation.
To investigate whether GB1asa allows phosphorylation of
EKR1/2 with similar efficiency as heterodimeric GABAB recep-
tor, we expressed either GB1asa, or GB1 wild type (GB1) and
GB2, at the cell surface with comparable expression levels
(Fig 1C). In these assays, all transfected GB1asa trafficked to the
cell surface (Fig 1C) and baclofen-induced ERK1/2 phosphory-
lation was higher in cells co-expressing both GB1 and GB2 than
that of cells overexpressing GB1asa (Fig 1D), suggesting that
though GB1asa may form a functional receptor at the cell surface
in the absence of GB2, its efficacy was less than heterodimeric
GABAB receptor.
We have shown previously that GABAB receptor induced
ERK1/2 phosphorylation through GB2 subunits [21]. We
therefore tested whether GB1asa-mediated ERK1/2 phosphory-
lation is due to endogenous GB2. By using antibodies against the
C-terminus of GB1 and GB2 or antibodies against the epitope tag
fused to the N-terminals of GB1 and GB2, we found that no
endogenous GB1 or GB2 was detectable in HEK293 cells
(Fig. 2A). Furthermore, we also failed to detect any GB2 mRNA
expression in HEK293 cells (Fig. 2B). It has been shown that a
positive allosteric modulator, CGP7930, can increase GABAB
receptor downstream signaling through binding to GB2 subunits
trans-membrane domains [21,25]. Indeed, we found that whereas
CGP7930 increases GABA-induced ERK1/2 phosphorylation in
cells overexpressing both GB1 and GB2, CGP7930 failed to do so
in cells expressing GB1asa alone (Fig. 2C), further demonstrating
that GB1asa induced ERK1/2 phosphorylation via a GB2-
independent pathway.
GB1asa Induces ERK1/2 Phosphorylation via IGF-1R
Transactivation and Gi/o-protein/PLC pathway
We next examined how GB1asa induced ERK1/2 phosphory-
lation. We have recently reported that GABAB receptor protected
neurons from apoptosis via IGF-1R transactivation [22]. Here, we
investigated whether IGF-1R mediated the phosphorylation of
ERK1/2 induced by GB1asa. Both GABA (100 mM) and baclofen
(100 mM) induced IGF-1R phosphorylation in a transient manner
without altering IGF-1R protein expression in GB1asa-tranfected
HEK293 cells (Fig. 3A). We further performed the experiments
with either a pharmacological inhibitor, AG1024 (a specific
inhibitor of IGF-IR phosphorylation), or RNAi knock-down
approaches. Indeed, AG1024 pretreatment inhibited GABA-
Figure 2. GB1asa-mediated ERK1/2 activation is independent of GABAB2. (A) Endogenous expression of GB2 is undetectable in HEK293
cells. Western blots of cell lysates performed with anti-HA or anti-GB1 antibodies (upper panel), anti-Flag or anti-GB2 antibodies (middle panel) and
anti-Src antibody (bottom panel). Cells were transfected without or with
HAGB1,
FlagGB2,
HAGB1with
FlagGB2 and
HAGB1asa. (B) No GB2 mRNA can be
detected in HEK293 cells. HEK293 cells transfected with human GB1 or human GB1 with human GB2 are used as negative and positive control
respectively. Images are representative of at least three independent RT-PCR analyses. (C) Time course of the ERK1/2 phosphorylation induced by
GABA (100 mM) in the absence or presence of CGP7930 (25 mM) in the HEK293 cells transfected with both GB1 and GB2 (left panel) or GB1asa alone
(right panel). All western blots shown here are representative of at least three separate experiments.
doi:10.1371/journal.pone.0039698.g002
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cells (Fig. 3B upper panel). Furthermore, transfection of IGF-1R
RNAi (IGF-R3467) also inhibited GABA-induced ERK1/2 phos-
phorylationbyreducingendogenousIGF-1RexpressioninGB1asa-
transfected MEF cells; whereas, scrambled RNAi (P-SIH-H1) had
no such effect (Fig. 3B lower panel). In all, these results
demonstrated that GB1asa induced ERK1/2 phosphorylation
through IGF-1R transactivation.
We have previously shown that GABAB receptor transactivated
IGF-1R through Gi/o proteins [22]. Pertussis toxin (PTX)
pretreatment (200 ng/ml) abolished GB1asa-induced IGF-1R
and ERK1/2 phosphorylation (Fig. 3C), suggesting that Gi/o
proteins are involved in GB1asa-mediated IGF-1R transactivation,
which in turn induces ERK1/2 phosphorylation.
Functional GABAB receptor has also been shown to enhance
phospholipase C (PLC) activity through the Gbc subunits [22]. We
examined the possible involvement of PLC on GB1asa-induced
ERK1/2 phosphorylation. We found that pretreating cells with
U73122, an inhibitor of PLC, but not its inactive analog U73343,
completely abolished ERK1/2 phosphorylation (Fig. 3D), thus
suggesting that GB1asa-induced ERK1/2 activation is mediated
through PLC.
Figure 3. GB1asa-mediated ERK1/2 phosphorylation requires IGF-1R transactivation through Gi/o proteins and PLC pathway. (A)
Effects of GABA (100 mM) and Baclofen (100 mM) on IGF-1R phosphorylation in cells overexpressing GB1asa for the indicated time course. (B) Effect of
AG1024 (upper panel) and shRNA of IGF-1R (3476) (lower panel) on GABA-stimulated ERK1/2 phosphorylation. AG1024 (0.1 mM; 60 min) is incubated
before treatment with GABA (100 mM; 5 min) in HEK293 cells overexpressing GB1asa. The shRNA knock-down assay is performed in MEF cells
overexpressing GB1asa. (C) Effect of PTX on GABA-stimulated IGF-1R and ERK1/2 phosphorylation. PTX (200 ng/ml; 16 hrs) is incubated before and
during treatment with GABA (100 mM; 5 min). (D) Effect of U73122 and U73343 on GABA-stimulated ERK1/2 phosphorylation. U73122 (5 mM; 60 min)
or U73343 (5 mM; 60 min) are incubated before treatment with GABA (100 mM; 5 min). The western blots shown are representative of at least three
separate experiments.
doi:10.1371/journal.pone.0039698.g003
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Phosphorylation is Greater than Induction by Wild
type GB1
It has been shown that intracellular GB1 alone induces
ERK1/2 phosphorylation [26]. Here we compared the effect
induced either by GB1 or GB1asa. We expressed either
GB1asa, or GB1 wild type (GB1) with comparable expression
levels, whereas only GB1asa could be expressed at the cell
surface (Fig 4A). Under these conditions, GB1asa-induced
ERK1/2 phosphorylation was much higher than GB1-induced
ERK1/2 phosphorylation (Fig 4B), suggesting that cell surface
located GB1 more efficiently induces ERK1/2 phosphorylation
than intracellular GB1.
Discussion
In the present study, we demonstrated that a GB1 mutant,
GB1asa, was able to act at the cell surface to induce ERK1/2
phosphorylation in a manner independent of GB2. Furthermore,
we found that GB1asa-induced ERK1/2 phosphorylation acts via
Gi/o-proteins and the PLC-mediated IGF-1R transactivation
(Fig 4C).
Hetero-dimerization is a prerequisite for native GABAB
receptor function. GB2 masks the ER retention signal located at
the C-terminus of GB1, thereby allowing GB1 to reach the cell
surface [2,10–12]. However, the temporal and spatial expression
profiles of GB1 and GB2 do not always coincide [1,3,13,18],
suggesting that GB1 is functional in the absence of GB2.
Furthermore, several lines of evidence suggest that GB1,
Figure 4. In the absence of GB2, GB1asa induction of ERK1/2 phosphorylation is greater than induction by wild type GB1. (A)
Detection of the cell surface expression of GB1 or GB1asa (upper panel) and total expression by Western blots with anti-HA and anti-b-actin (lower
panel). (B) Time course of the endogenous ERK1/2 phosphorylation induced by GABA (100 mM) in the HEK293 cells transfected with GB1asa or GB1
alone. (C) Schematic representation of the signaling pathway mediated by GB1asa at the cell surface. Activation of ERK1/2 phosphorylation by GB1asa
requires Gi/o proteins to activate PLC pathway, which in turn transactivates IGF-IR.
doi:10.1371/journal.pone.0039698.g004
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ERK1/2 phosphorylation and regulates leptin mRNA expression
[26,28]. However, all of these reports failed to detect obvious cell
surface expression of GB1 in the absence of GB2. It is likely that
GB1 alone has activity, possibly as a homodimer on the ER and
ER-Golgi intermediate compartment [29]. However, it remains
unclear how ligands can enter the cell to induce a rapid response
through intracellular receptors. To circumvent these issues, we use
the ER retention signal mutant of GB1, GB1asa, which can
translocate to the cell surface independently of GB2, to show that
GB1asa at the cell surface can act as a functional receptor to
induce ERK1/2 phosphorylation. Furthermore, GB1asa-induced
ERK1/2 phosphorylation is much higher than mediated by
transfected wild type GB1, suggesting that cell surface expression
of GB1 allows for more efficient ERK1/2 activation. How
intracellular GB1 induces ERK1/2 phosphorylation remains for
further investigation.
Even though GB1asa utilizes an artificial mechanism to allow
translocation to the plasma membrane, it is probable that GB1 can
be trafficked to the cell surface in the absence of GB2. It has been
shown that a novel GPCR interacting scaffolding protein (GISP)
can facilitate the transportation of GB1 to the cell surface by direct
interaction with the coiled-coil domain of GB1 C-terminus, thus
allowing translocation of GB1 independent of GB2 [30].
Furthermore, association of GB1 with the GABAA receptor c2S
subunit promotes GB1 cell surface expression in the absence of
GB2 [31]. Further efforts need to be devoted to elucidating the
mechanisms that allow traffic of GB1 towards the cell surface in
the absence of GB2.
Our data shows that GB1asa at the cell surface in the absence of
GB2 is sufficient to activate ERK1/2 via Gi/o proteins and PLC
pathway, though with less efficiency than in the presence of GB2.
Gi/o proteins are pre-associated with GABAB receptor [32,33].
GABAB receptor transactivates IGF-1R through Gi/o protein bc
subunits, which in turn activates the PLC pathway [22]. bc
subunits of G proteins produced by GABAB receptor enhance the
mGluR-mediated Gq response [34]. It is possible that preassem-
bled Gi/o proteins interact with GB1. Upon activation, GB1 could
induce Gi/o proteins bc subunits to transactivate IGF-1R via the
PLC pathway. Although no Gi/o proteins coupled to GB1 in the
absence of GB2 has been previously detected [8,9,35,36], our
results suggest that GB1 retains the ability to couple Gi/o proteins
in the absence of GB2, but with decreased efficiency. Whether and
how GB1alone interacts with Gi/o proteins needs to be further
characterized.
In summary, our data demonstrate that a plasma membrane
localized GB1 mutant, GB1asa, induced ERK1/2 phosphoryla-
tion through Gi/o proteins and PLC-dependent transactivation of
IGF-1R. These results provide the first evidence that GB1 at the
cell surface may exert the same function as heterodimeric GABAB
receptor, suggesting a novel mechanism of activation by this
receptor.
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